Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00928837 · ClinicalTrials.gov registry record · NA
Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
A NA study, sponsored by Primus Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT00928837: Completed NA study, sponsored by Primus Pharmaceuticals.
NCT00928837 is a NA study that has completed, run by Primus Pharmaceuticals. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00928837, a NA study, has completed, sponsored by Primus Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the efficacy and safety of flavocoxid (Limbrel) with Naproxen and placebo in OA of the knee.
Primary Outcome
comparison of short WOMAC and timed walk
Interventions
- OTHER Placebo
- DRUG Naproxen
- DIETARY_SUPPLEMENT Flavocoxid 500 mg
- OTHER flavocoxid 250 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00928837 record still lists
NCT00928837 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00928837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00928837 about?
NCT00928837 is a clinical study titled "Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee". The purpose of the study is to compare the efficacy and safety of flavocoxid (Limbrel) with Naproxen and placebo in OA of the knee.
What is the current status of trial NCT00928837?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2006-03. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00928837?
The interventions under investigation include: Placebo (OTHER), Naproxen (DRUG), Flavocoxid 500 mg (DIETARY_SUPPLEMENT), flavocoxid 250 mg (OTHER).
Who is sponsoring clinical trial NCT00928837?
This trial is sponsored by Primus Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00928837's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia